Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA276163
Max Phase: Preclinical
Molecular Formula: C49H62N12O11
Molecular Weight: 995.11
Molecule Type: Small molecule
Associated Items:
ID: ALA276163
Max Phase: Preclinical
Molecular Formula: C49H62N12O11
Molecular Weight: 995.11
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)Nc1cc(Cc2ccc(O)cc2)cc(C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)O)c1
Standard InChI: InChI=1S/C49H62N12O11/c1-27(2)41(60-44(67)36(10-6-16-54-49(51)52)57-43(66)35(50)24-40(63)64)46(69)56-32-20-30(18-29-12-14-34(62)15-13-29)19-31(22-32)42(65)58-37(23-33-25-53-26-55-33)47(70)61-17-7-11-39(61)45(68)59-38(48(71)72)21-28-8-4-3-5-9-28/h3-5,8-9,12-15,19-20,22,25-27,35-39,41,62H,6-7,10-11,16-18,21,23-24,50H2,1-2H3,(H,53,55)(H,56,69)(H,57,66)(H,58,65)(H,59,68)(H,60,67)(H,63,64)(H,71,72)(H4,51,52,54)/t35-,36-,37-,38-,39-,41-/m0/s1
Standard InChI Key: RTLACNATCIDGRQ-ZYWZKTPASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 995.11 | Molecular Weight (Monoisotopic): 994.4661 | AlogP: 0.27 | #Rotatable Bonds: 25 |
Polar Surface Area: 379.74 | Molecular Species: ZWITTERION | HBA: 12 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 15 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.53 | CX Basic pKa: 13.72 | CX LogP: -3.65 | CX LogD: -3.62 |
Aromatic Rings: 4 | Heavy Atoms: 72 | QED Weighted: 0.02 | Np Likeness Score: -0.08 |
1. Georgsson J, Sköld C, Plouffe B, Lindeberg G, Botros M, Larhed M, Nyberg F, Gallo-Payet N, Gogoll A, Karlén A, Hallberg A.. (2005) Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity., 48 (21): [PMID:16220978] [10.1021/jm050280z] |
Source(1):